Global Inhaled Nitric Oxide 麻豆原创 Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Publication ID:

PB505256035

Publication Date:

May 9, 2024

Pages:

133

Publisher:

MRRPB5

Countries:

Global [1]

USD 5,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
The global Inhaled Nitric Oxide market is projected to reach US$ 1906.6 million by 2030 from an estimated US$ 1181.6 million in 2024, at a CAGR of 8.3% during 2024 and 2030.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
麻豆原创 Segmentation
By Company
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Segment by Type
800 ppm
100 ppm
Others
Segment by Application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Inhaled Nitric Oxide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Inhaled Nitric Oxide Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Inhaled Nitric Oxide 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Inhaled Nitric Oxide 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Near-term and Pre-term Infants PPHN
1.3.3 Children and Adult ARDS
1.3.4 Other Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhaled Nitric Oxide 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Inhaled Nitric Oxide Revenue 2019-2030
2.1.2 Global Inhaled Nitric Oxide Sales 2019-2030
2.2 Inhaled Nitric Oxide 麻豆原创 Size by Region: 2023 Versus 2030
2.3 Inhaled Nitric Oxide Sales by Region (2019-2030)
2.3.1 Global Inhaled Nitric Oxide Sales by Region: 2019-2024
2.3.2 Global Inhaled Nitric Oxide Sales Forecast by Region (2025-2030)
2.3.3 Global Inhaled Nitric Oxide Sales 麻豆原创 Share by Region (2019-2030)
2.4 Inhaled Nitric Oxide 麻豆原创 Estimates and Projections by Region (2025-2030)
2.4.1 Global Inhaled Nitric Oxide Revenue by Region: 2019-2024
2.4.2 Global Inhaled Nitric Oxide Revenue Forecast by Region (2025-2030)
2.4.3 Global Inhaled Nitric Oxide Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Inhaled Nitric Oxide by Manufacturers
3.1 Global Top Inhaled Nitric Oxide Manufacturers by Sales
3.1.1 Global Inhaled Nitric Oxide Sales by Manufacturer (2019-2024)
3.1.2 Global Inhaled Nitric Oxide Sales 麻豆原创 Share by Manufacturer (2019-2024)
3.2 Global Top Inhaled Nitric Oxide Manufacturers by Revenue
3.2.1 Global Inhaled Nitric Oxide Revenue by Manufacturer (2019-2024)
3.2.2 Global Inhaled Nitric Oxide Revenue Share by Manufacturer (2019-2024)
3.3 Global Inhaled Nitric Oxide Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Inhaled Nitric Oxide Manufacturers Covered: Ranking by Revenue
3.4.2 Global Inhaled Nitric Oxide 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Inhaled Nitric Oxide 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Inhaled Nitric Oxide Manufacturing Base Distribution, Product Type
3.5.1 Inhaled Nitric Oxide Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Inhaled Nitric Oxide Product Type
3.5.3 Date of International Manufacturers Enter into Inhaled Nitric Oxide 麻豆原创
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Mallinckrodt
4.1.1 Mallinckrodt Company Information
4.1.2 Mallinckrodt Description, Business Overview
4.1.3 Mallinckrodt Inhaled Nitric Oxide Products Offered
4.1.4 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Mallinckrodt Inhaled Nitric Oxide Sales by Product in 2023
4.1.6 Mallinckrodt Inhaled Nitric Oxide Sales by Application in 2023
4.1.7 Mallinckrodt Inhaled Nitric Oxide Sales by Geographic Area in 2023
4.1.8 Mallinckrodt Recent Developments
4.2 Praxair (Linde plc)
4.2.1 Praxair (Linde plc) Company Information
4.2.2 Praxair (Linde plc) Description, Business Overview
4.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Products Offered
4.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Product in 2023
4.2.6 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Application in 2023
4.2.7 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Geographic Area in 2023
4.2.8 Praxair (Linde plc) Recent Developments
4.3 Air Liquide
4.3.1 Air Liquide Company Information
4.3.2 Air Liquide Description, Business Overview
4.3.3 Air Liquide Inhaled Nitric Oxide Products Offered
4.3.4 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Air Liquide Inhaled Nitric Oxide Sales by Product in 2023
4.3.6 Air Liquide Inhaled Nitric Oxide Sales by Application in 2023
4.3.7 Air Liquide Inhaled Nitric Oxide Sales by Geographic Area in 2023
4.3.8 Air Liquide Recent Developments
4.4 BOC Healthcare (Linde Group)
4.4.1 BOC Healthcare (Linde Group) Company Information
4.4.2 BOC Healthcare (Linde Group) Description, Business Overview
4.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Products Offered
4.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
4.4.5 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Product in 2023
4.4.6 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Application in 2023
4.4.7 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Geographic Area in 2023
4.4.8 BOC Healthcare (Linde Group) Recent Developments
5 Breakdown Data by Type
5.1 Global Inhaled Nitric Oxide Sales by Type (2019-2030)
5.1.1 Global Inhaled Nitric Oxide Sales by Type (2019-2024)
5.1.2 Global Inhaled Nitric Oxide Sales Forecast by Type (2025-2030)
5.1.3 Global Inhaled Nitric Oxide Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Inhaled Nitric Oxide Revenue Forecast by Type (2019-2030)
5.2.1 Global Inhaled Nitric Oxide Revenue by Type (2019-2024)
5.2.2 Global Inhaled Nitric Oxide Revenue Forecast by Type (2025-2030)
5.2.3 Global Inhaled Nitric Oxide Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Inhaled Nitric Oxide Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Inhaled Nitric Oxide Sales by Application (2019-2030)
6.1.1 Global Inhaled Nitric Oxide Sales by Application (2019-2024)
6.1.2 Global Inhaled Nitric Oxide Sales Forecast by Application (2025-2030)
6.1.3 Global Inhaled Nitric Oxide Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Inhaled Nitric Oxide Revenue Forecast by Application (2019-2030)
6.2.1 Global Inhaled Nitric Oxide Revenue by Application (2019-2024)
6.2.2 Global Inhaled Nitric Oxide Revenue Forecast by Application (2025-2030)
6.2.3 Global Inhaled Nitric Oxide Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Inhaled Nitric Oxide Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Inhaled Nitric Oxide 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Inhaled Nitric Oxide 麻豆原创 Facts & Figures by Country
7.2.1 North America Inhaled Nitric Oxide Sales by Country (2019-2030)
7.2.2 North America Inhaled Nitric Oxide Revenue by Country (2019-2030)
7.3 North America Inhaled Nitric Oxide Sales by Type (2019-2024)
7.4 North America Inhaled Nitric Oxide Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Inhaled Nitric Oxide 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Inhaled Nitric Oxide 麻豆原创 Facts & Figures by Region
8.2.1 Asia-Pacific Inhaled Nitric Oxide Sales by Region (2019-2030)
8.2.2 Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2019-2030)
8.3 Asia-Pacific Inhaled Nitric Oxide Sales by Type (2019-2024)
8.4 Asia-Pacific Inhaled Nitric Oxide Sales by Application (2019-2024)
9 Europe
9.1 Europe Inhaled Nitric Oxide 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Inhaled Nitric Oxide 麻豆原创 Facts & Figures by Country
9.2.1 Europe Inhaled Nitric Oxide Sales by Country (2019-2030)
9.2.2 Europe Inhaled Nitric Oxide Revenue by Country (2019-2030)
9.3 Europe Inhaled Nitric Oxide Sales by Type (2019-2024)
9.4 Europe Inhaled Nitric Oxide Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Inhaled Nitric Oxide 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Inhaled Nitric Oxide 麻豆原创 Facts & Figures by Country
10.2.1 Latin America Inhaled Nitric Oxide Sales by Country (2019-2030)
10.2.2 Latin America Inhaled Nitric Oxide Revenue by Country (2019-2030)
10.3 Latin America Inhaled Nitric Oxide Sales by Type (2019-2024)
10.4 Latin America Inhaled Nitric Oxide Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Inhaled Nitric Oxide 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Inhaled Nitric Oxide 麻豆原创 Facts & Figures by Country
11.2.1 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2019-2030)
11.2.2 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2019-2030)
11.3 Middle East and Africa Inhaled Nitric Oxide Sales by Type (2019-2024)
11.4 Middle East and Africa Inhaled Nitric Oxide Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Inhaled Nitric Oxide Supply Chain Analysis
12.2 Inhaled Nitric Oxide Key Raw Materials and Upstream Suppliers
12.3 Inhaled Nitric Oxide Clients Analysis
12.4 Inhaled Nitric Oxide Sales Channel and Sales Model Analysis
12.4.1 Inhaled Nitric Oxide Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Inhaled Nitric Oxide Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Inhaled Nitric Oxide Distributors
13 麻豆原创 Dynamics
13.1 Inhaled Nitric Oxide Industry Trends
13.2 Inhaled Nitric Oxide 麻豆原创 Drivers
13.3 Inhaled Nitric Oxide 麻豆原创 Challenges
13.4 Inhaled Nitric Oxide 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.